Tuesday, October 4

Tag: investing

McDonald’s CEO Makes a Big Political Statement (Some Won’t Like It)
Politics

McDonald’s CEO Makes a Big Political Statement (Some Won’t Like It)

Chief executives and political commentary rarely go well together — when outgoing Whole Foods CEO John Mackey went on a podcast to say that the "socialists are taking over" and young people "don’t seem like they want to work," the internet did not let him retire without one last scandal.The latest person to make a splash with his remarks is McDonald's  (MCD)  chief executive Chris Kempczinski. During a conference at the Economic Club of Chicago, Kempczinski drew attention to the issue of crime in the Midwestern metropolis that serves as the headquarters of the Golden Arches.The city alone has more than 400 restaurants and, Kempczinski told reporters at the event, rising crime has been making it difficult to run many of them.ShutterstockKempczinski: 'Violent Crime In Our Restaurants'"We hav...
What do retail and pharmacy have in common? How RFID technology can serve as part of a comprehensive solution to diversion
Science

What do retail and pharmacy have in common? How RFID technology can serve as part of a comprehensive solution to diversion

Retail and pharmacy – two very different industries that, on the surface, might not appear to have much in common. However, the two fields have found a use for an emerging technology to solve very similar problems. Radio frequency identification (RFID) technology is an incredibly valuable resource that has been introduced in the retail space to track inventory and detect and deter theft. Now, RFID is bringing immense value to the healthcare space,continuing to show promise and results, especially when incorporated into a comprehensive drug diversion prevention program. RFID technology uses wireless communication and radio waves to identify and track items and equipment. RFID tags can store a significant amount of data, whether it be a single serial number or several pages of material. Wi...
The new paradigm in drug development: Why platform technology is the solution patients and payers need
Science

The new paradigm in drug development: Why platform technology is the solution patients and payers need

We are living in a dynamic time of drug development and innovation with many beneficiaries—the most important being the patient. These developments include everything from exciting gene therapies for rare diseases to mRNA technology that allowed the development of the COVID vaccine in record time. Yet we are facing significant challenges as well. There is a global call for more equitable pricing and broader access—especially for the newer innovative treatments. How can we as healthcare leaders answer that call? How can we work with our stakeholders to ensure that the system can effectively support new innovations so that the most important stakeholder—the patient—will benefit? Collaboration and partnerships In answering the call, we must focus our attention on where it has the most impa...
Twitter Should Be a Public Service Instead of Elon Musk’s Private Business
Business

Twitter Should Be a Public Service Instead of Elon Musk’s Private Business

Text size A monitor with Twitter Inc. signage on the floor of the New York Stock Exchange (NYSE) in New York, U.S., on Friday, April 29, 2022. Michael Nagle/Bloomberg About the author: Anamitra Deb is the managing director at Omidyar Network. Can Elon Musk generate new revenue streams and turn around Twitter’s bottom line? How will he deal with issues like free speech, content moderation, open-sourci...